SCHEMBL735839

SCHEMBL735839

c1ccc2c(c1)ncn2CCc1c[nH]c2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.55
HTT P42858 1/20 0.55
MKNK1 Q9BUB5 3/20 0.54
MKNK2 Q9HBH9 3/20 0.54
HTR2A P28223 2/20 0.51
CDK4 P11802 1/20 0.50
CCND1 P24385 1/20 0.50
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TP53 P04637 1/20 0.49
PKM P14618 1/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
HTR1A P08908 1/20 0.48
LMNA P02545 2/20 0.48
MPO P05164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL736172 0.85 CDK4 (0.65) TDP1HTTHTR2ACDK4CCND1
SCHEMBL6442808 0.74 TDP1 (1.00) TDP1HTTNPC1RAB9ASMN1; SMN2
SCHEMBL6162492 0.72 EGLN3 (0.60) TDP1HTTNPC1RAB9ASMN1; SMN2
SCHEMBL734714 0.72 NPC1 (0.64) NPC1RAB9ASMN1; SMN2TP53PKM
SCHEMBL4985934 0.72 HTR2A (0.77) TDP1HTTHTR2AKMT2AMEN1
SCHEMBL784573 0.71 HTT (1.00) TDP1HTTSMN1; SMN2PKMMAPK1
SCHEMBL29188240 0.71 HTR2A (0.64) TDP1HTTHTR2ACDK4CCND1
SCHEMBL19882113 0.71 HTR6 (0.51) HTTHTR2ACDK4CCND1NPC1
SCHEMBL14851019 0.71 TDP1 (0.78) TDP1HTTNPC1RAB9ASMN1; SMN2
SCHEMBL29788835 0.70 HTR2A (0.55) TDP1HTTHTR2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 TDP1 3736/4885HTT 247/4885MKNK1 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.